SINOVAC BIOTECH LTD Deferred Income Tax Assets, Net
SINOVAC BIOTECH LTD (SVA) had Deferred Income Tax Assets, Net of $41.52 million as of 2025-12-31, per its 20-F filed 2026-06-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2026-06-05
- 2025-12-31: Deferred Income Tax Assets, Net $41.52M.
- 2024-12-31: Deferred Income Tax Assets, Net $37.37M.
- 2023-12-31: Deferred Income Tax Assets, Net $38.23M; Deferred Income Tax Assets, Net as first filed $29.79M.
- 2022-12-31: Deferred Income Tax Assets, Net $30.13M; Deferred Income Tax Assets, Net as first filed $71.12M.
| Period end | Deferred Income Tax Assets, Net | Deferred Income Tax Assets, Net as first filed |
|---|---|---|
| 2025-12-31 | $41.52M 20-F · filed 2026-06-05 | |
| 2024-12-31 | $37.37M 20-F · filed 2026-06-05 | |
| 2023-12-31 | $38.23M 20-F · filed 2026-04-30 | $29.79M 20-F · filed 2024-04-29 |
| 2022-12-31 | $30.13M 20-F · filed 2026-04-30 | $71.12M 20-F · filed 2023-05-01 |
| 2021-12-31 | $27.56M 20-F · filed 2026-04-30 | $52.03M 20-F · filed 2022-04-29 |
| 2020-12-31 | $26.89M 20-F · filed 2022-04-29 | |
| 2019-12-31 | $11.37M 20-F · filed 2021-04-22 |